Fundraising FoxEdison Oncology Holding
Menlo Park, US · Founded 2018 · Nevada corporation
Find your way into Edison Oncology Holding
Sign up to see every warm intro you have to Edison Oncology Holding
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Edison Oncology Holding team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Edison Oncology develops innovative cancer therapies through collaboration with leading scientific and clinical experts from the life sciences industry and academic partners.
Founders & leadership
JA
Jeffrey A BachaNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$882.6K disclosed across 3 rounds · 2018–2020
▶$250KraisedApr 2021 · 7 investors · PharmaceuticalsRule 506(c)
▶$250KraisedApr 2021 · 7 investors · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- Jeffrey A BachaExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $250K
- Sales commissions
- $25K
- Placement agents
- NewBridge Securities Corporation
- First sale
- Dec 2020
- Incorporated
- Corporation, Nevada, 2018
- Federal exemptions
- 06c
▶$632.5KraisedOct 2018 · 16 investors · OtherRule 506(b)
▶$632.5KraisedOct 2018 · 16 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Sean MartinExecutive Officer, Director
- Jeffrey BachaExecutive Officer, Director
- Brett NeslandExecutive Officer
- Offering amount
- $632.5K
- Amount sold
- $632.5K
- First sale
- Oct 2018
- Incorporated
- Corporation, Nevada, 2018
- Federal exemptions
- 06b
▶$125raisedSep 2018 · 18 investors · OtherRule 506(b)
▶$125raisedSep 2018 · 18 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Brett NeslandExecutive Officer
- Sean MartinExecutive Officer, Director
- Jeffrey BachaExecutive Officer, Director
- Offering amount
- $125
- Amount sold
- $125
- First sale
- Sep 2018
- Incorporated
- Corporation, Nevada, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
TargetedoncTargeted Oncology is a medical news and education publication for oncologists and cancer care professionals, covering clinical trial data, FDA approvals, treatment guidelines, and expert commentary across cancer types. It delivers conference coverage, podcasts, videos, and short-form content focused on precision oncology and targeted cancer therapies.
PowerPower builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment. The company operates in the healthcare technology and clinical research industry.
MD Anderson Cancer CenterUT MD Anderson is a cancer research and treatment center that provides patient care, conducts research, and offers education in cancer prevention and treatment. It is part of the University of Texas System and operates as a nonprofit medical institution.
Companies working in the same space as Edison Oncology Holding.
In the news
Frequently asked questions
- What does Edison Oncology Holding do?
- Edison Oncology develops innovative cancer therapies through collaboration with leading scientific and clinical experts from the life sciences industry and academic partners.
- How much funding has Edison Oncology Holding raised?
- Edison Oncology Holding has disclosed $882.6K raised across 3 rounds.
- Where is Edison Oncology Holding headquartered?
- Edison Oncology Holding is headquartered in Menlo Park, US.